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Introduction
HIV research greatly benefits from the use of immunodefi-
cient mouse systems that are susceptible to HIV target
cells. Usually, immunodeficient mice are transplanted with
primary human cells to develop a “human” immune sys-
tem. Following engraftment, the animals are subsequently
infected with HIV. Here, we applied a different approach
and personalized mice by directly transplanting cells from
an HIV-infected patient.
Materials and methods
CD4+ T cells were isolated from a HIV-infected post
treatment controller (PTC) and transplanted into 6 week
old Rag2-/-gc-/- (Rag-hu) mice in order to monitor virus
replication over time.
Upon presentation to the clinic in 1998, the patient’s
viral load was 52.000 HIV copies/ml with near-normal
CD4+ T cell count of 491/ul and slightly reduced CD4
+/CD8+ ratio of 0,4. Treatment with AZT, 3TC and effa-
virenz was initiated and the viral load was undetectable
after few weeks and undetectable for the next couple of
years. In May 2004 therapy was stopped after more then
5 years in an attempt of STI (structured treatment inter-
ruption). Remarkably, the viral load stayed below the level
of detection with stable CD4+ counts since then. The
patient was further analyzed for host factors but neither
the HLA molecules (HLA A 01,02, B44, B52) nor a dele-
tion of the CCR5 receptor could account for the control of
the virus after treatment interruption.
Results
At 8 weeks after transplantation the mice were engrafted
with 15-30% human CD45+CD3+ and significant viral
loads (from 3 - 62 x 10E6) were detected. Analysis of lym-
phoid cells of the spleen, bone marrow, liver and salivary
gland demonstrated a fully established HIV infection.
Conclusion
The direct transplantation of patient-derived cells into
hemato-lymphoid system mice provides a novel experi-
mental approach to analyze the presence of replication-
competent HIV in patients with undetectable viral loads
such as, for example, post treatment controllers (PTC).
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